Effect of Prostaglandin E1 on arteriosclerosis obliterans in diabetic patients

被引:0
|
作者
Sano, H [1 ]
Narimiya, M [1 ]
Matsushima, M [1 ]
Asao, K [1 ]
Takemura, T [1 ]
Kawaguchi, M [1 ]
Tajima, N [1 ]
Hiratsuka, A [1 ]
机构
[1] Jikei Univ, Sch Med, Minato Ku, Tokyo, Japan
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The aim of this study is to evaluate the effect of Prostaglandin E-1 on arteriosclerosis obliterans in diabetic patients. In the present study, it is clear that the continuous intravenous administration of PGE(1) at 120 mug/day for 3 weeks has significantly improved subjective symptoms evaluated by the visual analogue scale, such as, coldness, numbness and pain in the lower extremities. Moreover, the circulatory status in the lower extremities was evaluated using the cold stress test by the thermography. Thus, it is indicated that the continuous intravenous administration of PGE(1) should significantly improve the circulatory status as well as subjective symptoms. (arteriosclerosis obliterans, prostaglandin E-1,diabetic patients, cold stress test, visual analogue scale, thermography).
引用
收藏
页码:313 / 316
页数:4
相关论文
共 50 条
  • [1] Effects of Prostaglandin E1 Infusion on Limb Hemodynamics and Vasodilatory Response in Patients with Arteriosclerosis Obliterans
    Shinji Makita
    Motoyuki Nakamura
    Atsushi Ohhira
    Shigehiro Itoh
    Katsuhiko Hiramori
    Cardiovascular Drugs and Therapy, 1997, 11 : 441 - 448
  • [2] Effects of prostaglandin E-1 infusion on limb hemodynamics and vasodilatory response in patients with arteriosclerosis obliterans
    Makita, S
    Nakamura, M
    Ohhira, A
    Itoh, S
    Hiramori, K
    CARDIOVASCULAR DRUGS AND THERAPY, 1997, 11 (03) : 441 - 448
  • [3] Effect of prostaglandin E1 on peritoneal membrane transport in CAPD-treated diabetic patients
    Jaroszynski, Andrzej J.
    Ksiazek, Andrzej
    PERITONEAL DIALYSIS INTERNATIONAL, 2008, 28 (05): : 538 - 540
  • [4] Prostaglandin E1 for preventing the progression of diabetic kidney disease
    Wang, Han
    Deng, Jue Lin
    Yue, Jirong
    Li, Jun
    Hou, Yan Bin
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [5] CLINICAL-EXPERIENCE WITH PROSTAGLANDIN-E1 IN THE TREATMENT OF ARTERIOSCLEROSIS OBLITERANS - A PRELIMINARY-REPORT
    AMBRUS, JL
    TAHERI, P
    KILLION, D
    DONALDSON, G
    JOURNAL OF MEDICINE, 1983, 14 (01) : 1 - 15
  • [6] EFFECT OF PROSTAGLANDIN E1 ON FOREARM BLOOD FLOW
    BEVEGARD, S
    ORO, L
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1969, 23 (04): : 347 - &
  • [7] EFFECT OF PROSTAGLANDIN E1 ON INTESTINAL MOTILITY OF CAT
    TURKER, RK
    ONUR, R
    ARCHIVES INTERNATIONALES DE PHYSIOLOGIE ET DE BIOCHIMIE, 1971, 79 (03): : 535 - &
  • [8] EFFECT OF PROSTAGLANDIN E1 ON CARDIOVASCULAR DYNAMICS IN DOGS
    MCCURDY, JR
    NAKANO, J
    TEXAS REPORTS ON BIOLOGY AND MEDICINE, 1967, 25 (03) : 489 - &
  • [9] Effect of prostaglandin E1 in patients with advanced lung cancer treated with chemotherapy
    Ren, Hai-Xia
    Tian, Lian-Tian
    Zhang, Liang
    Yang, Bo
    Li, Lei
    Li, Ming-Jiang
    Zhang, Wei-Dong
    Li, Xiao-Ping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03): : 2285 - 2291
  • [10] The effect of prostaglandin E1 on experimental colitis in the rat
    T. Terzioğlu
    T. Yaltι
    S. Tezelman
    International Journal of Colorectal Disease, 1997, 12 : 63 - 66